Cardiac and Vascular Diseases: Pathogenesis, Pharmacological Treatments, Advances in Therapies (2nd Edition)
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 57
Special Issue Editors
Interests: heart failure; cardiomyopathies; cardiac physiology; cardiorenal syndrome; cardiovascular pharmacology
Special Issues, Collections and Topics in MDPI journals
Interests: noninvasive assessment; heart failure; arrhythmias; preventive cardiology; cardiovascular pharmacology; cardio-oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular diseases are the leading cause of death worldwide. The relationship between cardiac and vascular structures is not always considered, and these diseases are often underdiagnosed.
The focus of this Special Issue is to develop new insights into the pathogenesis of vascular alterations in cardiac diseases by outlining the complex genetic, biochemical, and molecular aspects at the center of these alterations.
Early identification of cardiac and vascular diseases as well as the correct evaluation of mechanisms and pathogenetic pathways will help to promote the development of targeted therapies.
This Special Issue also aims to cover the landscape of cardiovascular pharmacology. Authors are invited to contribute their research in the field of pharmacological approaches to cardiac and vascular diseases by outlining the most recent advances in therapies and treatments.
The combination of research in pathogenesis and pharmacology will give a comprehensive overview of cardiovascular diseases and the attempts to improve outcomes for patients.
Dr. Francesco Massari
Dr. Pietro Scicchitano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endothelial function
- cardiomyopathies
- cardiovascular pharmacology
- cardiac therapeutics
- noninvasive vascular treatments
- molecular cardiac biomarkers
- molecular vascular biomarkers
